Role of Hormones in Hidradenitis Suppurativa (HS) and Other Skin Diseases

Role of Hormones in Hidradenitis Suppurativa (HS) and Other Skin Diseases

Es posible que algunos contenidos no estén disponibles en español.

Purpose of this Study

We are doing this study to understand how sex hormones (chemicals that tell cells and body parts to do certain things), such as estrogens and androgens, impact skin diseases like hidradenitis suppurativa (HS). To better understand this, we are enrolling both people who have diagnosed skin diseases and healthy volunteers who have no skin issues.

Who Can Participate?

Eligibility

Adults 18 years of age or older who: If you are a candidate with skin disease
  • Are diagnosed with HS or any other skin condition that is currently active
  • Can independently complete surveys about your symptoms
If you are a healthy candidate
  • Are diagnosed with HS or any other skin condition that is currently active
  • Can independently complete surveys about your symptoms
  • Are willing to have skin biopsies
For more information about who can join this study, please contact the study team at connor.whatley@duke.edu.

Age Range

18-110
Looking for Healthy Participants
Yes

What is Involved?

Description

If you choose to join this study, we will record demographic information such as your age, sex, race/ethnicity, and email address. We will also review your medical chart to find information that will be helpful in understanding your skin's health and condition. At each visit, we will ask you to complete questionnaires in addition to collecting labs that include:
  • Blood draws
  • Skin biopsies of normal and affected skin
  • Skin swabs
  • Skin tape stripping
  • Locations

    Duke University Hospital

    Visit Timing

    Weekdays

    Compensation

    Yes

    Spanish Materials Available

    No

    Study Details

    Full Title

    Role of hormones in hidradenitis suppurativa and other skin diseases

    Principal Investigator

    Tarannum
    Jaleel

    Protocol Number

    PRO00105932

    Phase

    N/A

    Enrollment Status

    Open to Enrollment